In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
How can the ICC punish Bangladesh for withdrawing from the T20 World Cup? What do the rules say?
The T20 World Cup 2026 is just days away, but a major controversy has erupted due to the stubborn
The Assam government is not imposing rules to control the population but is working towards popul
SC On IIT Student: The Supreme Court on Monday helped a poor student while giving an extraordinar
Why did Dr. Harsh Vardhan speak to Manmohan Singh - Congress leaders do not think like you
Former PM Manmohan Singh wrote a letter to Prime Minister Narendra Modi mentioning ways to contro
'Appear by 3 PM tomorrow...', DGCA summons IndiGo CEO Pieter Elbers again over the IndiGo crisis.
Following the Indigo crisis, the government's strict action now looms over the airline's senior o
The Central Board of Secondary Education's Term-2 examinations for classes X and XII are going to
The American space agency NASA is preparing to launch its Moon mission 'Artemis-1' once again aft
Agniveer Recruitment Scheme: Dates have come for the recruitment of Agniveers in the Indian Army
Amidst the threat of corona infection, the state government has issued a new guideline for corona
Due to Omicron worldwide, the pace of corona infection has become uncontrollable. In the last 24
